Key result
Having any cardiometabolic disease increased the risk of developing depressive symptoms (HR 1.10) compared to those without such diseases, with the effect primarily observed in older adults with lower socioeconomic status.
Why the study?
To investigate the effect of cardiometabolic diseases on the development of depressive symptoms and evaluate whether socioeconomic status moderates this relationship.
Does the presence of cardiometabolic diseases increase the risk of developing depressive symptoms in individuals free from depression at baseline?
Cohort (n=6,455)
Yes
Does the presence of cardiometabolic diseases increase the risk of developing depressive symptoms in individuals free from depression at baseline?
Hazard Ratio: 1.1 (95% CI 1.01–1.2)
Cardiometabolic diseases are associated with a modestly increased risk of developing depressive symptoms, particularly among older adults with lower socioeconomic status.
Should not yet change practice; extends observational evidence on cardiometabolic-depression links in older, lower-SES adults.
The aim of this study is to investigate the effect of cardiometabolic diseases (CMDs) on the development of depressive symptoms and to determine whether socioeconomic status (SES) moderates this effect. A total of 6,455 individual free from depressive symptoms were selected from the China Health and Retirement Longitudinal Study (CHARLS). CMDs and SES were self-reported. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CESD-10). Cox proportional hazards regression models were employed to examine the association between baseline CMDs and subsequent depressive symptoms. Stratified analysis were conducted to explore the moderating effect of SES on this association.Participants with any CMDs exhibited a higher risk of developing depressive symptoms compared to those without CMDs, with a hazard ratio (HR) of 1.10 (95% CI: 1.01, 1.20). Individuals with one CMD (HR = 1.08, 95% CI: 1.00, 1.20) or cardiometabolic multimorbidity (HR = 1.13, 95% CI: 1.02, 1.26) also demonstrated an increased risk. The effect of CMDs on depressive symptoms was observed primarily in adults aged 60 years and older with lower education attainment (HR = 1.28, 95%CI: 1.12, 1.46), lower income (HR = 1.29, 95%CI: 1.11, 1.50) and rural residency (HR = 1.29, 95%CI: 1.12,1.51). These findings emphasize the importance of closely monitoring the mental status of patients with CMDs and considering routine screening and evaluation for depressive symptoms, especially in individuals with low SES.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2025) conducted a cohort in Cardiometabolic diseases and depressive symptoms (n=6,455). Cardiometabolic diseases vs. No cardiometabolic diseases was evaluated on Development of depressive symptoms (HR 1.10, 95% CI 1.01, 1.20). Having any cardiometabolic disease increased the risk of developing depressive symptoms (HR 1.10) compared to those without such diseases, with the effect primarily observed in older adults with lower socioeconomic status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: